Chijioke Nze

Peer-Reviewed Articles

1. Nze C, Andersen CR, Ayers AA, Westin J, Wang M, Iyer S, Ahmed S, Pinnix C, Vega F, Nguyen L, McNeill L, Nastoupil LJ, Zhang K, Bauer CX, Flowers CR. Impact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHL. Blood Adv 8(14):3825-3837, 2024. PMID: 38607394.
2. Gunther JR, Xu J, Bhutani MS, Strati P, Fang PQ, Wu SY, Dabaja BS, Dong W, Bhosale PR, Flowers CR, Nair R, Malpica Castillo L, Fayad L, Iyer SP, Parmer S, Wang M, Lee HJ, Samaniego F, Westin J, Ahmed S, Nze CC, Jain P, Neelapu SS, Rodriguez MA, Chihara D, Nastoupil LJ, Pinnix CC. Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial. Lancet Haematol 11(7):e521-e529, 2024. PMID: 38843856.
3. Nze C, Andersen CR, Ayers AA, Westin J, Wang M, S Iyer, Ahmed S, Pinnix, Vega, Nguyen L, Nastoupil LJ, Zhang K, Bauer CX, Flowers CR. Impact of Patient Demographics and Neighborhood Socioeconomic Variables on Clinical Trial Participation Patterns for Non-Hodgkin Lymphoma. Blood Advances None(None):None, 2024. PMID: None.
4. Nze, CC, Msaouel, P, Derbala, M, Stephen, B, Abonofal, A, Meric-Bernstam, F, Tannir, NM, Naing, A. A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma. Cancers 15(15), 2023. PMID: 37568622.
5. Li A, De Las Pozas G, Andersen CR, Nze CC, Toale KM, Milner EM, Fillmore NR, Chiao EY, Rojas Hernandez C, Kroll MH, Merriman KW, Flowers CR. External validation of a novel electronic risk score for cancer-associated thrombosis in a comprehensive cancer center. Am J Hematol 98(7):1052-1057, 2023. e-Pub 2023. PMID: 37067102.
6. Nwanaji-Enwerem JC, Nze C, Cardenas A. Long-term Aspirin Use and Epigenetic Mitotic Clocks for Cancer Risk Prediction: Findings in Healthy Colon Mucosa and Recommendations for Future Epigenetic Aging Studies. Epigenetics Commun 1(1):None, 2021. e-Pub 2021. PMID: 35493198.
7. Nze C, Fortin B, Freedman R, Mandell E, Puligandla M, Neuberg D, Achebe M. Sudden death in sickle cell disease: current experience. Br J Haematol 188(4):e43-e45, 2020. e-Pub 2019. PMID: 31804704.
8. Eberly LA, Richterman A, Beckett AG, Wispelwey B, Marsh RH, Cleveland Manchanda EC, Chang CY, Glynn RJ, Brooks KC, Boxer R, Kakoza R, Goldsmith J, Loscalzo J, Morse M, Lewis EF, Abel S, Adams A, Anaya J, Andrews EH, Atkinson B, Avutu V, Bachorik A, Badri O, Bailey M, Baird K, Bakshi S, Balaban D, Barshop K, Baumrin E, Bayomy O, Beamesderfer J, Becker N, Berg DD, Berman AN, Blum SM, Boardman AP, Boden K, Bonacci RA, Brown S, Campbell K, Case S, Cetrone E, Charrow A, Chiang D, Clark D, Cohen AJ, Cooper A, Cordova T, Cuneo CN, de Feria AA, Deffenbacher K, DeFilippis EM, DeGregorio G, Deutsch AJ, Diephuis B, Divakaran S, Dorschner P, Downing N, Drescher C, D'Silva KM, Dunbar P, Duong D, Earp S, Eckhardt C, Elman SA, England R, Everett K, Fedotova N, Feingold-Link T, Ferreira M, Fisher H, Foo P, Foote M, Franco I, Gilliland T, Greb J, Greco K, Grewal S, Grin B, Growdon ME, Guercio B, Hahn CK, Hasselfeld B, Haydu EJ, Hermes Z, Hildick-Smith G, Holcomb Z, Holroyd K, Horton L, Huang G, Jablonski S, Jacobs D, Jain N, Japa S, Joseph R, Kalashnikova M, Kalwani N, Kang D, Karan A, Katz JT, Kellner D, Kidia K, Kim JH, Knowles SM, Kolbe L, Kore I, Koullias Y, Kuye I, Lang J, Lawlor M, Lechner MG, Lee K, Lee S, Lee Z, Limaye N, Lin-Beckford S, Lipsyc M, Little J, Loewenthal J, Logaraj R, Lopez DM, Loriaux D, Lu Y, Ma K, Marukian N, Matias W, Mayers JR, McConnell I, McLaughlin M, Meade C, Meador C, Mehta A, Messenger E, Michaelidis C, Mirsky J, Mitten E, Mueller A, Mullur J, Munir A, Murphy E, Nagami E, Natarajan A, Nsahlai M, Nze C, Okwara N, Olds P, Paez R, Pardo M, Patel S, Petersen A, Phelan L, Pimenta E, Pipilas D, Plovanich M, Pong D, Powers BW, Rao A, Ramirez Batlle H, Ramsis M, Reichardt A, Reiger S, Rengarajan M, Rico S, Rome BN, Rosales R, Rotenstein L, Roy A, Royston S, Rozansky H, Rudder M, Ryan CE, Salgado S, Sanchez P, Schulte J, Sekar A, Semenkovich N, Shannon E, Shaw N, Shorten AB, Shrauner W, Sinnenberg L, Smithy JW, Snyder G, Sreekrishnan A, Stabenau H, Stavrou E. Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center. Circ Heart Fail 12(11):e006214, 2019. e-Pub 2019. PMID: 31658831.
9. Green AR, Rosu C, Kenison T, Nze C. Assessing the hidden curriculum for the care of patients with limited english proficiency: An instrument development. Educ Health (Abingdon) 31(1):17-24, 2018. PMID: 30117468.

Other Articles

1. Green AR, Nze C Language-Based Inequity in Health Care: Who Is the "Poor Historian"?. AMA J Ethics 19(3):263-271, 2017. PMID: 28323607.

Editorials

1. Nze C, Flowers. Barriers to accessing cellular therapy for patients receiving care in community practices. Hematology Am Soc Hematol Educ Program 2023(1):382-385, 2023. PMID: 38066850.
2. Nze, Nastoupil LJ. CAR T-cell Therapy: A Major Shift in the Treatment Landscape for Early-Relapse Aggressive B-Cell Lymphomas. The Hematologist 20(1):None, 2023. PMID: None.
3. Nze C. The Impact of Race on Mortality and Relapse in TTP. Practice update None(None):None, 2022. PMID: None.
4. Nze C, Flowers CR. Analyzing Racial and Ethnic Disparities in Multiple Myeloma FDA Drug Approval Trials. Practice update None(None):None, 2022. PMID: None.
5. Nze C. Association of Race/Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Enrolled in VA and Medicare. Practice update None(None):None, 2022. PMID: None.
6. Nze C, Flowers CR. Potential Impact of Nurse Navigation Program in Achieving Equitable Care and Outcomes in Patients With Aggressive Large B-Cell Lymphoma. ASCO Post None(None):None, 2021. PMID: None.
7. Nze C. Socioeconomic Status and Suboptimal Iron Deficiency Screening in Pregnancy. Practice update None(None):None, 2021. PMID: None.
8. Nze C. Eliminating Race-Based Reference Ranges in Hematology. Practice update None(None):None, 2021. PMID: None.
9. Nze C, Avakame E, Ayankola J. Police brutality is our lane too, doctors say. STAT None(None):None, 2020. PMID: None.

Abstracts

1. Nair R, Ogundipe I, Gunther J, Medeiros L, Jain P, Nastoupil LJ, Pinnix CC, Malpica L, Ahmed S, Miranda R, Fayad L, Steiner RE, Hagemeister F, Lee HJ, Rodriguez MA, Strati P, Chihara D, Wang M, Nieto Y, Ramdial J, Zaki AA, Nze C, Green MR, Dabaja BS, Xu J, Thakral B, Neelapu SS, Vega F, Flowers CR, Fang P, Westin J, Feng L, Iyer SP. Outcomes in Patients with Relapsed Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Treated with CAR-T Cell Therapies or Salvage Chemotherapy - a Single-Institution Experience. Blood 142(1):6327, 2023. PMID: None.
2. Graham T, Ackbarali T, Nze C, Bryant A, Duque AD, Flowers CR. Perceptions and Practices of Clinical Trial Enrollment Among Patients with Non-Hodgkin Lymphoma, Caregivers, and Providers. Blood 142(1):2388, 2023. PMID: None.
3. Jiang JY, Nze C, Guffey D, Kim R, Ouyomi AO, Rosales O, Bandyo R, Diamond A, Rivero GA, Miller-Chism CN, Udden MM, Mims MP, Flowers CR, Li A, Teegavarapu PS. Clinical Outcomes of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma in a County Hospital System. Blood 142(1):5140, 2023. PMID: None.
4. Nze C, Andersen CR, Ayers A, Westin J, Wang ML, Iyer SP, Ahmed S, Pinnix CC, Vega F, McNeil L, Nguyen L, Nastoupil LJ, Flowers CR. Impact of Patient Demographics and Neighborhood Socioeconomic Variables on Clinical Trial Participation Patterns for Non-Hodgkin Lymphoma at a Major Academic Institution. Blood 140(1):7943–7945, 2022. PMID: None.
5. Nze C, Fortin BM, Freedman R, Puligandla M, MS, Neuberg DS, ScD, Mandell E, ANP, Achebe M, MD MPH. Sudden Death in Sickle Cell Disease: An Assessment of Risk Factors. Blood None(None):None, 2018. PMID: None.